Ross Baker

10.8k total citations · 1 hit paper
136 papers, 6.0k citations indexed

About

Ross Baker is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ross Baker has authored 136 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Hematology, 31 papers in Internal Medicine and 29 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ross Baker's work include Platelet Disorders and Treatments (40 papers), Venous Thromboembolism Diagnosis and Management (31 papers) and Blood Coagulation and Thrombosis Mechanisms (28 papers). Ross Baker is often cited by papers focused on Platelet Disorders and Treatments (40 papers), Venous Thromboembolism Diagnosis and Management (31 papers) and Blood Coagulation and Thrombosis Mechanisms (28 papers). Ross Baker collaborates with scholars based in Australia, United States and United Kingdom. Ross Baker's co-authors include Mark N. Levine, Michael Gent, Frederick R. Rickles, Martin H. Prins, Jim A. Julian, Chris Bowden, Agnes Lee, Ajay K. Kakkar, Susan L. Haley and Michael J. Kovacs and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ross Baker

130 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

2003 1.8k citations Ross Baker, Frederick R. Rickles et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Ross Baker

Since Specialization

Citations

This map shows the geographic impact of Ross Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Baker more than expected).

Fields of papers citing papers by Ross Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Baker. The network helps show where Ross Baker may publish in the future.

Co-authorship network of co-authors of Ross Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Baker. A scholar is included among the top collaborators of Ross Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Baker. Ross Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2025 Guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri‐operative and bleeding management 2025 ·Internal Medicine Journal ·Huyen Tran, Eileen Merriman, Ross Baker, Jennifer Curnow, Laura Young, Chee-Wee Tan, Simon McRae, Sanjeev Chunilal	0
2	Management of Bleeding, Thrombotic and Pregnancy-Related Complications in Women with Myeloproliferative Neoplasms: A Case-Based Review Focusing on Sex-Specific Challenges 2025 ·Journal of Clinical Medicine ·Thita Chiasakul, Ross Baker	0
3	Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia 2024 ·Blood Advances ·David J. Kuter, Jiřı́ Mayer, (unknown), (unknown), Ross Baker, Zane Kaplan, Mamta Garg, Marek Trněný, Philip Choi, A.J. Gerard Jansen, Vickie McDonald, Robert Bird, Jaromír Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed Daak, Nichola Cooper	11
4	The aptamer BT200 blocks interaction of K1405-K1408 in the VWF-A1 domain with macrophage LRP1 2024 ·Blood ·Alain Chion, (unknown), Ferdows Atiq, (unknown), Sonia Águila, Judicaël Fazavana, (unknown), Ellie Karampini, (unknown), Roger J. S. Preston, Ross Baker, Thomas A. J. McKinnon, Shuhao Zhu, James C. Gilbert, Jonas Emsley, Bernd Jilma, James S. O’Donnell	15
5	Isatuximab plus carfilzomib and dexamethasone in patients with early <i>versus</i> late relapsed multiple myeloma: IKEMA subgroup analysis 2023 ·Haematologica ·Thierry Façon, Philippe Moreau, Ross Baker, Chang‐Ki Min, Xavier Leleu, Mohamad Mohty, Lionel Karlin, Nicole M. Armstrong, Christina Tekle, (unknown), Marie‐Laure Risse, Thomas G. Martin	11
6	Low von Willebrand Disease: A Bleeding Disorder of Unknown Cause? 2023 ·Hämostaseologie ·James S. O’Donnell, Ross Baker	5
7	Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19 2023 ·Research and Practice in Thrombosis and Haemostasis ·Ellie Karampini, Helen Fogarty, (unknown), (unknown), Colm Bergin, Jamie M. O’Sullivan, Mary Byrne, Ignacio Martín‐Loeches, Patrick Mallon, Gerard F. Curley, Siobhán Glavey, Ross Baker, Michelle Lavin, Roger J. S. Preston, Clíona Ní Cheallaigh, Soracha E. Ward, James S. O’Donnell	9
8	Examining international practices in the management of pregnant women with von Willebrand disease 2021 ·Journal of Thrombosis and Haemostasis ·Michelle Lavin, Analía Sánchez‐Luceros, Peter A. Kouides, Rezan A. Kadir, James S. O’Donnell, Ross Baker, Maha Othman, Sandra L. Haberichter	11
9	A Multicenter Trial of Vena Cava Filters in Severely Injured Patients 2019 ·New England Journal of Medicine ·Kwok M. Ho, Sudhakar Rao, Stephen Honeybul, René Zellweger, Bradley Wibrow, Jeffrey Lipman, Anthony Holley, Alan Kop, Elizabeth Geelhoed, Tomás Corcoran, (unknown), Cyrus Edibam, Ross Baker, Jenny Chamberlain, (unknown), Frederick B. Rogers	88
10	New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism 2019 ·The Medical Journal of Australia ·Huyen Tran, Harry Gibbs, Eileen Merriman, Jennifer Curnow, Laura Young, (unknown), Chee-Wee Tan, Sanjeev Chunilal, Chris Ward, Ross Baker, Harshal Nandurkar	87
11	Dimeric FcγR ectodomains detect pathogenic anti‐platelet factor 4–heparin antibodies in heparin‐induced thromobocytopenia 2018 ·Journal of Thrombosis and Haemostasis ·Bruce D. Wines, (unknown), Elizabeth M. Duncan, Simon McRae, Ross Baker, Robert K. Andrews, Sandra Esparon, Elizabeth E. Gardiner, P. Mark Hogarth	4
12	Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy 2017 ·BMC Research Notes ·(unknown), Ian James, (unknown), J. Tiao, Ross Baker	16
13	Long‐term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy 2013 ·British Journal of Haematology ·David J. Kuter, James B. Bussel, Adrian C. Newland, Ross Baker, Roger M. Lyons, Jeffrey S. Wasser, Jean‐François Viallard, Gail Macik, Mathias Rummel, Kun Nie, Susie Jun	203
14	Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study 2010 ·British Journal of Anaesthesia ·Kwok M. Ho, (unknown), Sudhakar Rao, Ross Baker	65
15	Undiagnosed Myeloproliferative Disease in Cases of Intra-Abdominal Thrombosis: The Utility of the JAK2 617F Mutation 2008 ·Clinical Gastroenterology and Hepatology ·(unknown), (unknown), Ross Baker, Nick Kontorinis, Wendy Cheng	9
16	The effects of tissue factor pathway inhibitor and anti-b-2-glycoprotein-I IgG on thrombin generation 2006 ·Murdoch Research Repository (Murdoch University) ·(unknown), Paul E. R. Ellery, (unknown), Jim Thom, (unknown), Michael F. Leahy, Ross Baker, MJ Adams	2
17	Laboratory Diagnosis of von Willebrand Disorder: Use of Multiple Functional Assays Reduces Diagnostic Error Rates 2005 ·PubMed ·Emmanuel J. Favaloro, Roslyn Bonar, (unknown), John Sioufi, Jim Thom, Ross Baker, Mark Hertzberg, Alison Street, J. V. Lloyd, Katherine Marsden	10
18	Once-Daily Enoxaparin in The Outpatient Setting Versus Unfractionated Heparin in Hospital for the Treatment of Symptomatic Deep-Vein Thrombosis 2005 ·Journal of Thrombosis and Thrombolysis ·Beng H. Chong, Tim Brighton, Ross Baker, Peter J. Thurlow, (unknown), (unknown)	39
19	A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE). 2002 ·Blood ·(unknown), (unknown), Ross Baker, C.L. Bowden, AK Kakkar, M.H. Prins, Frederick R. Rickles, (unknown), Susan L. Haley, M.J. Kovacs, Michael Gent	13
20	The effects of alcohol on coagulation and fibrinolytic factors 1998 ·Murdoch Research Repository (Murdoch University) ·Simon B. Dimmitt, Valentina Rakic, Ian B. Puddey, Ross Baker, (unknown), MJ Adams, (unknown), V. Burke, Lawrence J. Beilin	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact